Explaining variations in breast cancer screening across European countries

被引:26
作者
Wuebker, Ansgar [1 ]
机构
[1] Univ Witten Herdecke, Dept Econ Inst Econ & Hlth Syst Management, D-58448 Witten, Germany
关键词
Health economics; Prevention; Multilevel models; SHARE; Cross-country differences; MAMMOGRAPHY; HEALTH; WOMEN; INTERVENTIONS; DEMAND; DETERMINANTS; GUIDELINES; MORTALITY;
D O I
10.1007/s10198-013-0490-3
中图分类号
F [经济];
学科分类号
02 ;
摘要
In this study I aim to explore the statistical causes of country differences in mammography screening among women aged 50-69 years in 13 European countries. I focus on the relative importance of individual (e.g. age, education, etc.) and institutional (e.g. public screening programmes) factors in explaining these differences. I use individual level data from the first three waves (2004-2006-2009) of the SHARE as well as regional and country level data on institutional factors. The analytical approach is based on multilevel statistical models, which allow me to analyse the contribution of individual and institutional factors in explaining the variation in breast cancer screening across European countries. I find that the standard deviation in screening rates across countries increases slightly from 19.5 to 20.8 per cent after controlling for individual factors. Observed individual factors such as age, education, health status, etc., do not significantly contribute to the explanation of cross-country differences. In contrast, after controlling for observed institutional factors such as the availability of an organised screening programme, the standard deviation drops from 20.86 to 12.92 per cent. These factors can statistically explain about 40 per cent of the between-country differences in screening rates. Moreover, I found that these institutional factors seem to prevent a woman from considering a mammogram "not necessary". This analysis provides important insights about patient's attitudes and understanding of benefits of breast cancer prevention and highlights the importance of the availability of an organised screening programme for screening differences across European countries.
引用
收藏
页码:497 / 514
页数:18
相关论文
共 50 条
  • [21] Risk assessment, screening and prevention of breast cancer: A look at cost-effectiveness
    Lebovic, Gail S.
    Hollingsworth, Alan
    Feig, Stephen A.
    [J]. BREAST, 2010, 19 (04) : 260 - 267
  • [22] A health systems approach to identifying barriers to breast cancer screening programmes. Methodology and application in six European countries
    Turnbull, Eleanor
    Priaulx, Jennifer
    van Ravesteyn, Nicolien T.
    Heinavaara, Sirpa
    Siljander, Ilona
    Senore, Carlo
    Segnan, Nereo
    Voko, Zoltan
    Hagymasy, Judit
    Jarm, Katja
    Veerus, Piret
    de Koning, Harry J.
    McKee, Martin
    [J]. HEALTH POLICY, 2018, 122 (11) : 1198 - 1205
  • [23] Optimal two-stage breast cancer screening for countries with intermediate or low incidence of breast cancer
    Kuo, Shou-Jen
    Chen, Tony Hsiu-Hsi
    Yen, Amy Ming-Fang
    Chen, Dar-Ren
    Chen, Li-Sheng
    [J]. JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2010, 16 (06) : 1345 - 1352
  • [24] Interval breast cancer: Analysis of occurrence, subtypes and implications for breast cancer screening in a model region
    Daniaux, Martin
    Gruber, Leonhard
    Santner, Wolfram
    Czech, Theresa
    Knapp, Rudolf
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2021, 143
  • [25] Diagnose earlier, live longer? The impact of cervical and breast cancer screening on life span
    Yang, Zhenjie
    Liu, Juan
    Wang, Qing
    [J]. PLOS ONE, 2022, 17 (07):
  • [26] Breast Cancer Knowledge, Attitude and Screening Behaviors Among Hispanics in South Texas Colonias
    Sunil, T. S.
    Hurd, Thelma
    Deem, Carma
    Nevarez, Lucinda
    Guidry, Jeffrey
    Rios, Rebecca
    Guerra, Hector
    Ortiz, Juanita
    Jones, Lovell
    [J]. JOURNAL OF COMMUNITY HEALTH, 2014, 39 (01) : 60 - 71
  • [27] Neoadjuvant Therapy in Rectal Cancer Patients With Clinical Stage II to III Across European Countries: Variations and Outcomes
    Babaei, Masoud
    Jansen, Lina
    Balavarca, Yesilda
    Sjovall, Annika
    Bos, Amanda
    van de Velde, Tony
    Moreau, Michel
    Liberale, Gabriel
    Goncalves, Ana Filipa
    Bento, Maria Jose
    Ulrich, Cornelia M.
    Schrotz-King, Petra
    Lemmens, Valery
    Glimelius, Bengt
    Brenner, Hermann
    [J]. CLINICAL COLORECTAL CANCER, 2018, 17 (01) : E129 - E142
  • [28] Should low-income countries invest in breast cancer screening?
    Gyawali, Bishal
    Shimokata, Tomoya
    Honda, Kazunori
    Tsukuura, Hiroaki
    Ando, Yuichi
    [J]. CANCER CAUSES & CONTROL, 2016, 27 (11) : 1341 - 1345
  • [29] Mammography screening and trust: The case of interval breast cancer
    Solbjor, Marit
    Skolbekken, John-Arne
    Saetnan, Ann Rudinow
    Hagen, Anne Irene
    Forsmo, Siri
    [J]. SOCIAL SCIENCE & MEDICINE, 2012, 75 (10) : 1746 - 1752
  • [30] Social support and breast cancer screening in rural Appalachia
    Smalls, Brittany L.
    Aroh, Adaeze
    McQuerry, Kristen
    Adegboyega, Adebola
    Schoenberg, Nancy
    Hatcher, Jennifer
    [J]. PSYCHO-ONCOLOGY, 2018, 27 (09) : 2281 - 2288